158 related articles for article (PubMed ID: 37740573)
1. Luteolin inhibits Porphyromonas gingivalis growth and alleviates alveolar bone destruction in experimental murine periodontitis.
Kariu T; Hamada N; Lakshmyya K
Biosci Biotechnol Biochem; 2023 Dec; 88(1):37-43. PubMed ID: 37740573
[TBL] [Abstract][Full Text] [Related]
2. Porphyromonas gulae Has Virulence and Immunological Characteristics Similar to Those of the Human Periodontal Pathogen Porphyromonas gingivalis.
Lenzo JC; O'Brien-Simpson NM; Orth RK; Mitchell HL; Dashper SG; Reynolds EC
Infect Immun; 2016 Sep; 84(9):2575-85. PubMed ID: 27354442
[TBL] [Abstract][Full Text] [Related]
3. The role of RgpA in the pathogenicity of Porphyromonas gingivalis in the murine periodontitis model.
Wilensky A; Polak D; Houri-Haddad Y; Shapira L
J Clin Periodontol; 2013 Oct; 40(10):924-32. PubMed ID: 23909600
[TBL] [Abstract][Full Text] [Related]
4. Application of Ginsenoside Rd in Periodontitis With Inhibitory Effects on Pathogenicity, Inflammation, and Bone Resorption.
Zhou S; Ji Y; Yao H; Guo H; Zhang Z; Wang Z; Du M
Front Cell Infect Microbiol; 2022; 12():813953. PubMed ID: 35480231
[TBL] [Abstract][Full Text] [Related]
5. Spirulina maxima reduces inflammation and alveolar bone loss in Porphyromonas gingivalis-induced periodontitis.
Kang MS; Moon JH; Park SC; Jang YP; Choung SY
Phytomedicine; 2021 Jan; 81():153420. PubMed ID: 33278781
[TBL] [Abstract][Full Text] [Related]
6. Mucosal Langerhans Cells Promote Differentiation of Th17 Cells in a Murine Model of Periodontitis but Are Not Required for Porphyromonas gingivalis-Driven Alveolar Bone Destruction.
Bittner-Eddy PD; Fischer LA; Kaplan DH; Thieu K; Costalonga M
J Immunol; 2016 Aug; 197(4):1435-46. PubMed ID: 27402698
[TBL] [Abstract][Full Text] [Related]
7. Porphyromonas gingivalis infection increases osteoclastic bone resorption and osteoblastic bone formation in a periodontitis mouse model.
Zhang W; Ju J; Rigney T; Tribble G
BMC Oral Health; 2014 Jul; 14():89. PubMed ID: 25027664
[TBL] [Abstract][Full Text] [Related]
8. Divergence of the systemic immune response following oral infection with distinct strains of Porphyromonas gingivalis.
Marchesan JT; Morelli T; Lundy SK; Jiao Y; Lim S; Inohara N; Nunez G; Fox DA; Giannobile WV
Mol Oral Microbiol; 2012 Dec; 27(6):483-95. PubMed ID: 23134613
[TBL] [Abstract][Full Text] [Related]
9. Morphometric, histomorphometric, and microcomputed tomographic analysis of periodontal inflammatory lesions in a murine model.
Li CH; Amar S
J Periodontol; 2007 Jun; 78(6):1120-8. PubMed ID: 17539727
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 signaling contributes to alveolar bone resorption in Porphyromonas gingivalis-induced periodontitis in mice.
Nagashima H; Shinoda M; Honda K; Kamio N; Hasuike A; Sugano N; Arai Y; Sato S; Iwata K
J Oral Sci; 2017 Dec; 59(4):571-577. PubMed ID: 29093284
[TBL] [Abstract][Full Text] [Related]
11. Experimental periodontitis induced by Porphyromonas gingivalis does not alter the onset or severity of diabetes in mice.
Li H; Yang H; Ding Y; Aprecio R; Zhang W; Wang Q; Li Y
J Periodontal Res; 2013 Oct; 48(5):582-90. PubMed ID: 23317150
[TBL] [Abstract][Full Text] [Related]
12. Blockade of sympathetic b-receptors inhibits Porphyromonas gingivalis-induced alveolar bone loss in an experimental rat periodontitis model.
Okada Y; Hamada N; Kim Y; Takahashi Y; Sasaguri K; Ozono S; Sato S
Arch Oral Biol; 2010 Jul; 55(7):502-8. PubMed ID: 20593554
[TBL] [Abstract][Full Text] [Related]
13. Functional assessment of peptide-modified PLGA nanoparticles against oral biofilms in a murine model of periodontitis.
Mahmoud MY; Steinbach-Rankins JM; Demuth DR
J Control Release; 2019 Mar; 297():3-13. PubMed ID: 30690103
[TBL] [Abstract][Full Text] [Related]
14. Mast Cells Contribute to Porphyromonas gingivalis-induced Bone Loss.
Malcolm J; Millington O; Millhouse E; Campbell L; Adrados Planell A; Butcher JP; Lawrence C; Ross K; Ramage G; McInnes IB; Culshaw S
J Dent Res; 2016 Jun; 95(6):704-10. PubMed ID: 26933137
[TBL] [Abstract][Full Text] [Related]
15. Stevioside reduces inflammation in periodontitis by changing the oral bacterial composition and inhibiting P. gingivalis in mice.
Han W; Jiao Y; Mi S; Han S; Xu J; Li S; Liu Y; Guo L
BMC Oral Health; 2023 Aug; 23(1):550. PubMed ID: 37563632
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Porphyromonas gingivalis-induced periodontal bone loss by CXCR4 antagonist treatment.
McIntosh ML; Hajishengallis G
Mol Oral Microbiol; 2012 Dec; 27(6):449-57. PubMed ID: 23134610
[TBL] [Abstract][Full Text] [Related]
17. Porphyromonas gingivalis-induced alveolar bone loss is accelerated in the stroke-prone spontaneously hypertensive rat.
Tokutomi F; Wada-Takahashi S; Sugiyama S; Toyama T; Sato T; Hamada N; Tsukinoki K; Takahashi SS; Lee MC
Arch Oral Biol; 2015 Jun; 60(6):911-8. PubMed ID: 25824310
[TBL] [Abstract][Full Text] [Related]
18. Long-term evaluation of oral gavage with periodontopathogens or ligature induction of experimental periodontal disease in mice.
de Molon RS; Mascarenhas VI; de Avila ED; Finoti LS; Toffoli GB; Spolidorio DM; Scarel-Caminaga RM; Tetradis S; Cirelli JA
Clin Oral Investig; 2016 Jul; 20(6):1203-16. PubMed ID: 26411857
[TBL] [Abstract][Full Text] [Related]
19. Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis.
Kuula H; Salo T; Pirilä E; Tuomainen AM; Jauhiainen M; Uitto VJ; Tjäderhane L; Pussinen PJ; Sorsa T
Infect Immun; 2009 Feb; 77(2):850-9. PubMed ID: 19029300
[TBL] [Abstract][Full Text] [Related]
20. Kava-241 reduced periodontal destruction in a collagen antibody primed Porphyromonas gingivalis model of periodontitis.
Alshammari A; Patel J; Al-Hashemi J; Cai B; Panek J; Huck O; Amar S
J Clin Periodontol; 2017 Nov; 44(11):1123-1132. PubMed ID: 28746780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
